Melissa Calton

Publications

• Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Aslan IR, Campos GM, Calton MA, Evans DS, Merriman RB, Vaisse C. Obes Surg. 2011; 21 (7): 930-4
• Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Calton MA, Ersoy BA, Zhang S, Kane JP, Malloy MJ, Pullinger CR, Bromberg Y, Pennacchio LA, Dent R, McPherson R, Ahituv N, Vaisse C. Hum Mol Genet. 2009; 18 (6): 1140-7
• Narrowing down the role of common variants in the genetic predisposition to obesity. Calton MA, Vaisse C. Genome Med. 2009; 1 (3): 31
• CEPH individuals are representative of the European American population: implications for pharmacogenetics. Meucci MA, Marsh S, Watters JW, McLeod HL. Pharmacogenomics. 2005; 6 (1): 59-63
• Pharmacogenomic discovery approaches: will the real genes please stand up? Walgren RA, Meucci MA, McLeod HL. J Clin Oncol. 2005; 23 (29): 7342-9
• Analysis of variation in mouse TPMT genotype, expression and activity. Watters JW, Zhang W, Meucci MA, Hou W, Ma MK, McLeod HL. Pharmacogenetics. 2004; 14 (4): 247-54
• Genome-wide discovery of loci influencing chemotherapy cytotoxicity. Watters JW, Kraja A, Meucci MA, Province MA, McLeod HL. Proc Natl Acad Sci U S A. 2004; 101 (32): 11809-14